About

Servaas Michielssens, PhD, CFA

Head of Healthcare, Thematic Global Equity

Download a photo

Servaas Michielssens is the Head of Healthcare at Candriam since 2024. Previously, he was Senior Fund Manager and Biotechnology Analyst with Candriam from 2016 to 2022.   

His other financial experience includes two years in private equity (from 2022), and two years as a risk analyst at Axa. Servaas began his career as a Doctoral Researcher at Katholieke Universiteit Leuven in 2007 and joined Max Planck Institute in Germany as a researcher in 2012.  

Servaas holds a Master in Science and a Ph.D. in Chemistry (Katholieke Universiteit Leuven). He has been a CFA Charterholder since 2018. 

Discover the latest articles by Servaas Michielssens

ESG, SRI, Healthcare, Servaas Michielssens, Linden Thomson

Time to Re-engage with Healthcare?

Healthcare share prices tend to reflect some trepidation leading up to and shortly after the US presidential elections, yet for the last five elections the sector outperformed in the 12 months following the election.
Q&A, Healthcare, Linden Thomson, Servaas Michielssens

Biotech investing: is there a doctor in the house?

Servaas Michielssens and Linden Thomson answer investors’ questions about a sector where depth of specialist knowledge is a prerequisite to consistent stock selection success.
Oncology, Q&A, Servaas Michielssens, Linden Thomson, Equities

Investing in oncology: forewarned is forearmed

Servaas Michielssens and Linden Thomson explain to investors the approach they used to create and develop an investment strategy in the oncology sector.
Research Paper, Oncology, ESG, SRI, Servaas Michielssens

Precision Oncology Powered by AI: A New Era for Cancer Treatment

Have you heard about radiotheranostics? This new field in medicine combines diagnosis and therapy. It involves using specially designed radioactive compounds that can both identify cancer cells and deliver targeted radiation therapy to destroy them. This is one of the latest developments of precision medicine, a domain that offers fascinating prospects in both early detection and specific treatment.
Loading...

Find it fast

Get information faster with a single click

Get insights straight to your inbox